237 related articles for article (PubMed ID: 2105829)
1. Incidence and pathophysiology of hypercalcemia.
Mundy GR
Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
[TBL] [Abstract][Full Text] [Related]
2. [Hypercalcemia and neoplasms: recent advances in pathogenesis].
Virgolini L; Gallizia C
Recenti Prog Med; 1990 Oct; 81(10):635-41. PubMed ID: 2291007
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of bone lesions in multiple myeloma and lymphoma.
Roodman GD
Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemic factors other than parathyroid hormone-related protein.
Mundy GR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):795-806. PubMed ID: 2673774
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of cancer-associated hypercalcemia.
Mundy GR
Semin Oncol; 1990 Apr; 17(2 Suppl 5):10-5. PubMed ID: 2185548
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of osteolytic bone destruction.
Mundy GR
Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological aspects and therapeutic approaches of tumoral osteolysis and hypercalcemia.
Bonjour JP; Rizzoli R
Recent Results Cancer Res; 1989; 116():29-39. PubMed ID: 2669066
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
Wysolmerski JJ; Broadus AE
Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
[TBL] [Abstract][Full Text] [Related]
10. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hypercalcaemia of malignancy.
Mundy GR
Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
[TBL] [Abstract][Full Text] [Related]
12. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cancer-induced hypercalcemia.
Rosol TJ; Capen CC
Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
Buchs B; Rizzoli R; Bonjour JP
Bone; 1991; 12(1):47-56. PubMed ID: 2054236
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
17. Ectopic production of calciotropic peptides.
Mundy GR
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):473-87. PubMed ID: 1935916
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic hypercalcemia].
Body JJ
Rev Med Brux; 1988 Nov; 9(9):425-8. PubMed ID: 3060931
[No Abstract] [Full Text] [Related]
19. Peptide mediators of hypercalcemia in malignancy.
Strewler GJ; Nissenson RA
Annu Rev Med; 1990; 41():35-44. PubMed ID: 2184736
[TBL] [Abstract][Full Text] [Related]
20. Emergency Management of Malignancy-Associated Hypercalcemia.
Dellay B; Groth M
Adv Emerg Nurs J; 2016; 38(1):15-25; quiz E1. PubMed ID: 26817427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
